Skip to content
Recall Observatory FDA recall evidence

Drug product

Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.

D-0060-2023

November 09, 2022

Class II

Product summary

Firm
ImprimisRx NJ
Event
Event 91140
Status
Terminated
Classification
Class II
Quantity
960 bottles
Official record key
drug-enforcement:D-0060-2023

Official wording

Reason: Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.

Code information: Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent